Top in ID: CDC creates guide to address staff burnout; AI can improve infection prevention
Click Here to Manage Email Alerts
The CDC released a guide for hospitals to address and reduce burnout among staff members. The guide recommends removing barriers to seeking care, communicating with employees and creating a 12-month plan to maintain employee wellbeing.
“We know hospital leaders have a lot of competing demands, and it can be overwhelming to know where to start when working to improve professional well-being,” Stefanie Simmons, MD, chief medical officer at the Dr. Lorna Breen Heroes’ Foundation, said in a press release.
It was the top story in infectious disease last week.
In another top story, experts at the European Congress of Clinical Microbiology and Infectious Diseases discussed how artificial intelligence could be leveraged to aid infection prevention efforts in hospitals. Some examples included using AI systems to identify where cleaning is needed in facilities or using facial recognition to ensure staff are wearing face masks properly.
Read these and more top stories in infectious disease below:
CDC outlines six steps hospitals can take to address burnout
The CDC published a guide that hospitals can use to reduce the risk for burnout among health care staff. Read more.
AI could help improve hospital infection prevention
Artificial intelligence could help hospitals improve infection prevention efforts and make their outbreak responses faster and more accurate, according to experts. Read more.
EHR-based intervention increases PrEP initiation among some primary care patients
Use of an electronic health record-based intervention significantly increased pre-exposure prophylaxis use among patients of primary care physicians who care for people with HIV, a randomized trial found. Read more.
Lawmakers reauthorize PEPFAR for 1 year as part of spending package
The U.S. House of Representatives reauthorized the U.S. President’s Emergency Plan for AIDS Relief for 1 year as part of a spending package, sending the plan to the Senate for consideration. In a perspective, Paul A. Volberding, MD, chief medical editor of Healio | Infectious Disease News, weighed in on the development, characterizing PEPFAR as a “remarkable story of success in expanding life-saving, state-of-the-art medical and public health measures to economically distressed populations in the global South.” Read more.
FDA authorizes emergency use of pemivibart for COVID-19 prevention
The FDA authorized emergency use of pemivibart for pre-exposure prophylaxis of COVID-19 in adults and adolescents aged 12 years and older weighing at least 40 kg. Read more.